Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HAE Haemonetics	$74.14 -0.6%	$72.03	$55.30 ▼ $94.99	$3.58B	0.39	593,426 shs	449,362 shs
MMSI Merit Medical Systems	$84.22 -1.0%	$92.95	$82.62 ▼ $111.45	$5.03B	0.65	721,993 shs	403,402 shs
QDEL QuidelOrtho	$26.33 -1.0%	$29.40	$23.77 ▼ $49.45	$1.80B	0.07	1.78 million shs	1.23 million shs
XRAY DENTSPLY SIRONA	$16.46 -2.3%	$16.05	$12.16 ▼ $27.95	$3.36B	0.94	2.53 million shs	2.08 million shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HAE Haemonetics	+0.28%	+0.21%	+3.41%	+20.55%	-18.58%
MMSI Merit Medical Systems	+0.70%	+1.32%	-7.86%	-10.15%	-1.70%
QDEL QuidelOrtho	+4.15%	-3.52%	-3.80%	-4.25%	-27.99%
XRAY DENTSPLY SIRONA	+2.68%	+6.58%	+8.85%	+22.90%	-35.34%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
HAE Haemonetics	4.9035 of 5 stars	4.5	3.0	0.0	4.3	2.3	1.7	2.5
MMSI Merit Medical Systems	4.5985 of 5 stars	4.4	1.0	0.0	3.8	2.7	2.5	1.3
QDEL QuidelOrtho	4.5334 of 5 stars	3.2	2.0	0.0	3.8	3.2	1.7	2.5
XRAY DENTSPLY SIRONA	4.1779 of 5 stars	2.1	3.0	4.2	3.8	2.6	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HAE Haemonetics	3.00	Buy	$97.30	31.24% Upside
MMSI Merit Medical Systems	2.89	Moderate Buy	$109.11	29.55% Upside
QDEL QuidelOrtho	2.43	Hold	$44.33	68.38% Upside
XRAY DENTSPLY SIRONA	2.17	Hold	$19.60	19.08% Upside

Current Analyst Ratings Breakdown

Latest QDEL, MMSI, HAE, and XRAY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/22/2025	XRAY DENTSPLY SIRONA	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$21.00
7/21/2025	XRAY DENTSPLY SIRONA	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
7/18/2025	MMSI Merit Medical Systems	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$108.00
7/16/2025	MMSI Merit Medical Systems	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
7/11/2025	HAE Haemonetics	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$95.00
7/9/2025	HAE Haemonetics	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$90.00
7/8/2025	MMSI Merit Medical Systems	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$108.00
6/26/2025	HAE Haemonetics	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$87.00
6/25/2025	HAE Haemonetics	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/23/2025	MMSI Merit Medical Systems	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$106.00 ➝ $110.00
5/21/2025	MMSI Merit Medical Systems	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$108.00 ➝ $112.00

(Data available from 7/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HAE Haemonetics	$1.36B	2.62	$7.16 per share	10.35	$16.34 per share	4.54
MMSI Merit Medical Systems	$1.39B	3.59	$5.55 per share	15.17	$23.67 per share	3.56
QDEL QuidelOrtho	$2.78B	0.64	$35.11 per share	0.75	$44.38 per share	0.59
XRAY DENTSPLY SIRONA	$3.79B	0.86	$7.19 per share	2.29	$9.77 per share	1.68

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HAE Haemonetics	$167.68M	$3.31	22.40	14.71	1.21	12.32%	26.37%	9.22%	8/7/2025 (Estimated)
MMSI Merit Medical Systems	$120.36M	$2.04	41.28	22.46	2.75	8.81%	15.52%	8.72%	7/30/2025 (Estimated)
QDEL QuidelOrtho	-$2.05B	-$4.97	N/A	8.20	N/A	-12.07%	4.71%	2.21%	7/30/2025 (Estimated)
XRAY DENTSPLY SIRONA	-$910M	-$4.54	N/A	8.66	1.20	-24.42%	14.31%	5.37%	7/30/2025 (Estimated)

Latest QDEL, MMSI, HAE, and XRAY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q1 2026	HAE Haemonetics	$1.02	N/A	N/A	N/A	$305.12 million	N/A
8/7/2025	Q2 2025	XRAY DENTSPLY SIRONA	$0.50	N/A	N/A	N/A	$929.67 million	N/A
7/30/2025	Q2 2025	MMSI Merit Medical Systems	$0.8480	N/A	N/A	N/A	$372.47 million	N/A
7/30/2025	Q2 2025	QDEL QuidelOrtho	$0.0122	N/A	N/A	N/A	$612.36 million	N/A
5/8/2025	Q4 2025	HAE Haemonetics	$1.22	$1.24	+$0.02	$1.17	$329.38 million	$330.60 million
5/8/2025	Q1 2025	XRAY DENTSPLY SIRONA	$0.29	$0.43	+$0.14	$0.10	$854.75 million	$879.00 million
5/7/2025	Q1 2025	QDEL QuidelOrtho	$0.61	$0.74	+$0.13	-$0.19	$694.97 million	$692.80 million
4/24/2025	Q1 2025	MMSI Merit Medical Systems	$0.75	$0.86	+$0.11	$0.49	$352.57 million	$355.35 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
HAE Haemonetics	N/A	N/A	N/A	N/A	N/A
MMSI Merit Medical Systems	N/A	N/A	N/A	N/A	N/A
QDEL QuidelOrtho	N/A	N/A	N/A	N/A	N/A
XRAY DENTSPLY SIRONA	$0.64	3.89%	N/A	N/A	13 Years

Latest QDEL, MMSI, HAE, and XRAY Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/21/2025	XRAY DENTSPLY SIRONA	quarterly	$0.16	3.92%	6/27/2025	6/27/2025	7/11/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HAE Haemonetics	1.12	1.62	0.99
MMSI Merit Medical Systems	0.51	4.87	3.26
QDEL QuidelOrtho	0.70	1.20	0.66
XRAY DENTSPLY SIRONA	0.79	1.10	0.76

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HAE Haemonetics	99.67%
MMSI Merit Medical Systems	99.66%
QDEL QuidelOrtho	99.00%
XRAY DENTSPLY SIRONA	95.70%

Insider Ownership

Company	Insider Ownership
HAE Haemonetics	1.84%
MMSI Merit Medical Systems	3.20%
QDEL QuidelOrtho	0.79%
XRAY DENTSPLY SIRONA	0.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HAE Haemonetics	3,023	48.04 million	47.16 million	Optionable
MMSI Merit Medical Systems	7,400	59.10 million	57.21 million	Optionable
QDEL QuidelOrtho	6,600	67.63 million	67.09 million	Optionable
XRAY DENTSPLY SIRONA	14,000	199.29 million	198.30 million	Optionable

QDEL, MMSI, HAE, and XRAY Headlines

Recent News About These Companies

DENTSPLY SIRONA's (XRAY) "Outperform" Rating Reiterated at Barrington Research

July 24 at 3:07 AM | americanbankingnews.com

Envestnet Asset Management Inc. Grows Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

July 23 at 3:43 AM | marketbeat.com

DENTSPLY SIRONA (NASDAQ:XRAY) Given "Hold" Rating at Needham & Company LLC

July 23 at 2:59 AM | americanbankingnews.com

DENTSPLY SIRONA (NASDAQ:XRAY) Receives "Outperform" Rating from Barrington Research

July 22 at 1:01 PM | marketbeat.com

Here's Why Dentsply International (XRAY) is a Strong Value Stock

July 22 at 10:40 AM | zacks.com

DENTSPLY SIRONA's (XRAY) Hold Rating Reiterated at Needham & Company LLC

July 21 at 11:46 AM | marketbeat.com

DENTSPLY SIRONA (NASDAQ:XRAY) Issues Q2 2025 Earnings Guidance

July 21 at 9:20 AM | marketbeat.com

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer

July 21 at 8:30 AM | globenewswire.com

Cwm LLC Increases Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

July 21 at 3:55 AM | marketbeat.com

Cerity Partners LLC Purchases 116,607 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

July 19, 2025 | marketbeat.com

XRAY vs. MMSI: Which Stock Is the Better Value Option?

July 18, 2025 | zacks.com

Are Investors Undervaluing Dentsply Sirona (XRAY) Right Now?

July 18, 2025 | zacks.com

FY2028 EPS Estimates for DENTSPLY SIRONA Raised by Analyst

July 17, 2025 | marketbeat.com

Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now

July 16, 2025 | zacks.com

Q2 EPS Estimates for DENTSPLY SIRONA Lifted by Analyst

July 16, 2025 | marketbeat.com

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Bank of New York Mellon Corp

July 16, 2025 | marketbeat.com

Brown Advisory Inc. Invests $679,000 in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

July 15, 2025 | marketbeat.com

Dentsply Sirona’s (XRAY) Long Road to Recovery Amid Economic Challenges

July 14, 2025 | msn.com

Dental 3D Printing Market Forecast Study 2025, with Leading Dental Companies and Innovators BEGO, Dentsply Sirona, WhipMix, Straumann, Ivoclar, Formlabs, SprintRay, Asiga, and Shining3D

July 14, 2025 | globenewswire.com

DENTSPLY SIRONA (NASDAQ:XRAY) Raised to "Buy" at Wall Street Zen

July 13, 2025 | marketbeat.com

Dentsply Sirona to Host Second Quarter Conference Call on August 7th

July 10, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

QDEL, MMSI, HAE, and XRAY Company Descriptions

Haemonetics NYSE:HAE

$74.14 -0.42 (-0.57%)

Closing price 03:59 PM Eastern

Extended Trading

$74.22 +0.08 (+0.11%)

As of 05:28 PM Eastern

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Merit Medical Systems NASDAQ:MMSI

$84.22 -0.84 (-0.99%)

Closing price 04:00 PM Eastern

Extended Trading

$85.82 +1.60 (+1.89%)

As of 07:57 PM Eastern

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

QuidelOrtho NASDAQ:QDEL

$26.33 -0.27 (-1.02%)

Closing price 04:00 PM Eastern

Extended Trading

$26.33 0.00 (0.00%)

As of 07:39 PM Eastern

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

DENTSPLY SIRONA NASDAQ:XRAY

$16.46 -0.39 (-2.31%)

Closing price 04:00 PM Eastern

Extended Trading

$16.55 +0.09 (+0.52%)

As of 07:36 PM Eastern

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time